IQVIA HOLDINGS INC. Acquisitions, Net of Cash Acquired
IQVIA HOLDINGS INC. (IQV) reported Acquisitions, Net of Cash Acquired of $37.00 million for the 3-month period ending 2026-03-31, per its 10-Q filed 2026-05-05.
Financial Statements › Cash Flow › Investing Activities
us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired · last filed 2026-05-05
- IQVIA HOLDINGS INC. payments to acquire businesses, net of cash acquired for the quarter ending 2026-03-31 was $37.00M, a 72.39% decline year-over-year.
- IQVIA HOLDINGS INC. payments to acquire businesses, net of cash acquired for the quarter ending 2025-12-31 was $916.00M, a 965.12% increase year-over-year.
- IQVIA HOLDINGS INC. payments to acquire businesses, net of cash acquired for the quarter ending 2025-09-30 was $483.00M, a 12.85% increase year-over-year.
- IQVIA HOLDINGS INC. payments to acquire businesses, net of cash acquired for the quarter ending 2025-06-30 was $181.00M, a 129.11% increase year-over-year.
- IQVIA HOLDINGS INC. payments to acquire businesses, net of cash acquired for fiscal 2025 was $1.71B, a 133.20% increase from fiscal 2024.
- IQVIA HOLDINGS INC. payments to acquire businesses, net of cash acquired for fiscal 2024 was $735.00M, a 16.10% decline from fiscal 2023.
- IQVIA HOLDINGS INC. payments to acquire businesses, net of cash acquired for fiscal 2023 was $876.00M, a 33.38% decline from fiscal 2022.
- IQVIA HOLDINGS INC. payments to acquire businesses, net of cash acquired for fiscal 2022 was $1.31B, a 9.81% decline from fiscal 2021.
| Period end | Payments to Acquire Businesses, Net of Cash Acquired 3 month | Payments to Acquire Businesses, Net of Cash Acquired 6 month | Payments to Acquire Businesses, Net of Cash Acquired 9 month | Payments to Acquire Businesses, Net of Cash Acquired 12 month | Payments to Acquire Businesses, Net of Cash Acquired 12 month as first filed |
|---|---|---|---|---|---|
| 2026-03-31 | $37.00M 10-Q · filed 2026-05-05 | $953.00M derived: sum of 2 quarters · filed 2026-05-05 | $1.44B derived: sum of 3 quarters · filed 2026-05-05 | $1.62B derived: sum of 4 quarters · filed 2026-05-05 | |
| 2025-12-31 | $916.00M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-17 | $1.40B derived: sum of 2 quarters · filed 2026-02-17 | $1.58B derived: sum of 3 quarters · filed 2026-02-17 | $1.71B 10-K · filed 2026-02-17 | |
| 2025-09-30 | $483.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-28 | $664.00M derived: sum of 2 quarters · filed 2025-10-28 | $798.00M 10-Q · filed 2025-10-28 | $884.00M derived: sum of 4 quarters · filed 2026-05-05 | |
| 2025-06-30 | $181.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-07-22 | $315.00M 10-Q · filed 2025-07-22 | $401.00M derived: sum of 3 quarters · filed 2026-05-05 | $829.00M derived: sum of 4 quarters · filed 2026-05-05 | |
| 2025-03-31 | $134.00M 10-Q · filed 2026-05-05 | $220.00M derived: sum of 2 quarters · filed 2026-05-05 | $648.00M derived: sum of 3 quarters · filed 2026-05-05 | $727.00M derived: sum of 4 quarters · filed 2026-05-05 | |
| 2024-12-31 | $86.00M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-17 | $514.00M derived: sum of 2 quarters · filed 2026-02-17 | $593.00M derived: sum of 3 quarters · filed 2026-02-17 | $735.00M 10-K · filed 2026-02-17 | |
| 2024-09-30 | $428.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-28 | $507.00M derived: sum of 2 quarters · filed 2025-10-28 | $649.00M 10-Q · filed 2025-10-28 | $656.00M derived: sum of 4 quarters · filed 2026-02-17 | |
| 2024-06-30 | $79.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-07-22 | $221.00M 10-Q · filed 2025-07-22 | $228.00M derived: sum of 3 quarters · filed 2026-02-17 | $653.00M derived: sum of 4 quarters · filed 2026-02-17 | |
| 2024-03-31 | $142.00M 10-Q · filed 2025-05-06 | $149.00M derived: sum of 2 quarters · filed 2026-02-17 | $574.00M derived: sum of 3 quarters · filed 2026-02-17 | $1.00B derived: sum of 4 quarters · filed 2026-02-17 | |
| 2023-12-31 | $7.00M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-17 | $432.00M derived: sum of 2 quarters · filed 2026-02-17 | $858.00M derived: sum of 3 quarters · filed 2026-02-17 | $876.00M 10-K · filed 2026-02-17 | |
| 2023-09-30 | $425.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-10-31 | $851.00M derived: sum of 2 quarters · filed 2024-10-31 | $869.00M 10-Q · filed 2024-10-31 | $1.17B derived: sum of 4 quarters · filed 2025-02-13 | |
| 2023-06-30 | $426.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-07-22 | $444.00M 10-Q · filed 2024-07-22 | $747.00M derived: sum of 3 quarters · filed 2025-02-13 | $1.29B derived: sum of 4 quarters · filed 2025-02-13 | |
| 2023-03-31 | $18.00M 10-Q · filed 2024-05-02 | $321.00M derived: sum of 2 quarters · filed 2025-02-13 | $869.00M derived: sum of 3 quarters · filed 2025-02-13 | $903.00M derived: sum of 4 quarters · filed 2025-02-13 | |
| 2022-12-31 | $303.00M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-13 | $851.00M derived: sum of 2 quarters · filed 2025-02-13 | $885.00M derived: sum of 3 quarters · filed 2025-02-13 | $1.31B 10-K · filed 2025-02-13 | |
| 2022-09-30 | $548.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-01 | $582.00M derived: sum of 2 quarters · filed 2023-11-01 | $1.01B 10-Q · filed 2023-11-01 | $1.48B derived: sum of 4 quarters · filed 2024-02-15 | |
| 2022-06-30 | $34.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-01 | $464.00M 10-Q · filed 2023-08-01 | $928.00M derived: sum of 3 quarters · filed 2024-02-15 | $1.86B derived: sum of 4 quarters · filed 2024-02-15 | |
| 2022-03-31 | $430.00M 10-Q · filed 2023-04-28 | $894.00M derived: sum of 2 quarters · filed 2024-02-15 | $1.82B derived: sum of 3 quarters · filed 2024-02-15 | $1.87B derived: sum of 4 quarters · filed 2024-02-15 | |
| 2021-12-31 | $464.00M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-15 | $1.39B derived: sum of 2 quarters · filed 2024-02-15 | $1.44B derived: sum of 3 quarters · filed 2024-02-15 | $1.46B 10-K · filed 2024-02-15 | |
| 2021-09-30 | $929.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-10-27 | $975.00M derived: sum of 2 quarters · filed 2022-10-27 | $994.00M 10-Q · filed 2022-10-27 | $1.05B derived: sum of 4 quarters · filed 2023-02-15 | |
| 2021-06-30 | $46.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-07-22 | $65.00M 10-Q · filed 2022-07-22 | $124.00M derived: sum of 3 quarters · filed 2023-02-15 | $150.00M derived: sum of 4 quarters · filed 2023-02-15 | |
| 2021-03-31 | $19.00M 10-Q · filed 2022-04-28 | $78.00M derived: sum of 2 quarters · filed 2023-02-15 | $104.00M derived: sum of 3 quarters · filed 2023-02-15 | $182.00M derived: sum of 4 quarters · filed 2023-02-15 | |
| 2020-12-31 | $59.00M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-15 | $85.00M derived: sum of 2 quarters · filed 2023-02-15 | $163.00M derived: sum of 3 quarters · filed 2023-02-15 | $177.00M 10-K · filed 2023-02-15 | |
| 2020-09-30 | $26.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-10-22 | $104.00M derived: sum of 2 quarters · filed 2021-10-22 | $118.00M 10-Q · filed 2021-10-22 | $245.00M derived: sum of 4 quarters · filed 2022-02-16 | |
| 2020-06-30 | $78.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-07-28 | $92.00M 10-Q · filed 2021-07-28 | $219.00M derived: sum of 3 quarters · filed 2022-02-16 | $479.00M derived: sum of 4 quarters · filed 2022-02-16 | |
| 2020-03-31 | $14.00M 10-Q · filed 2021-04-23 | $141.00M derived: sum of 2 quarters · filed 2022-02-16 | $401.00M derived: sum of 3 quarters · filed 2022-02-16 | $427.00M derived: sum of 4 quarters · filed 2022-02-16 | |
| 2019-12-31 | $127.00M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-16 | $387.00M derived: sum of 2 quarters · filed 2022-02-16 | $413.00M derived: sum of 3 quarters · filed 2022-02-16 | $588.00M 10-K · filed 2022-02-16 | |
| 2019-09-30 | $260.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-10-22 | $286.00M derived: sum of 2 quarters · filed 2020-10-22 | $461.00M 10-Q · filed 2020-10-22 | $515.00M derived: sum of 4 quarters · filed 2021-02-12 | |
| 2019-06-30 | $26.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-07-23 | $201.00M 10-Q · filed 2020-07-23 | $255.00M derived: sum of 3 quarters · filed 2021-02-12 | $283.00M derived: sum of 4 quarters · filed 2021-02-12 | |
| 2019-03-31 | $175.00M 10-Q · filed 2020-04-30 | $229.00M derived: sum of 2 quarters · filed 2021-02-12 | $257.00M derived: sum of 3 quarters · filed 2021-02-12 | $464.00M derived: sum of 4 quarters · filed 2021-02-12 | |
| 2018-12-31 | $54.00M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-12 | $82.00M derived: sum of 2 quarters · filed 2021-02-12 | $289.00M derived: sum of 3 quarters · filed 2021-02-12 | $309.00M 10-K · filed 2021-02-12 | |
| 2018-09-30 | $28.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-01 | $235.00M derived: sum of 2 quarters · filed 2019-11-01 | $255.00M 10-Q · filed 2019-11-01 | $584.00M derived: sum of 4 quarters · filed 2020-02-18 | |
| 2018-06-30 | $207.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-07-24 | $227.00M 10-Q · filed 2019-07-24 | $556.00M derived: sum of 3 quarters · filed 2020-02-18 | $813.00M derived: sum of 4 quarters · filed 2020-02-18 | |
| 2018-03-31 | $20.00M 10-Q · filed 2019-05-02 | $349.00M derived: sum of 2 quarters · filed 2020-02-18 | $606.00M derived: sum of 3 quarters · filed 2020-02-18 | $724.00M derived: sum of 4 quarters · filed 2020-02-18 | |
| 2017-12-31 | $329.00M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-18 | $586.00M derived: sum of 2 quarters · filed 2020-02-18 | $704.00M derived: sum of 3 quarters · filed 2020-02-18 | $854.00M 10-K · filed 2020-02-18 | |
| 2017-09-30 | $257.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-10-25 | $375.00M derived: sum of 2 quarters · filed 2018-10-25 | $525.00M 10-Q · filed 2018-10-25 | ||
| 2017-06-30 | $118.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-07-27 | $268.00M 10-Q · filed 2018-07-27 | |||
| 2017-03-31 | $150.00M 10-Q · filed 2018-05-04 | ||||
| 2016-12-31 | -$1.89B 10-K · filed 2019-02-19 | ||||
| 2015-12-31 | -$999.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-16 | -$32.00M 10-K · filed 2018-02-16 | -$31.73M 10-K · filed 2016-02-11 | ||
| 2015-09-30 | -$31.00M 10-Q · filed 2016-11-03 | ||||
| 2014-12-31 | -$201.00K derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-16 | $91.33M derived: sum of 2 quarters · filed 2017-02-16 | $91.33M derived: sum of 3 quarters · filed 2017-02-16 | $92.00M 10-K · filed 2017-02-16 | $92.20M 10-K · filed 2015-02-12 |
| 2014-09-30 | $91.53M derived: 10-Q 9 month − 10-Q 6 month · filed 2015-10-28 | $91.53M derived: sum of 2 quarters · filed 2015-10-28 | $92.20M 10-Q · filed 2015-10-28 | $92.20M derived: sum of 4 quarters · filed 2016-02-11 | |
| 2014-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2014-07-31 | $667.00K 10-Q · filed 2014-07-31 | $667.00K derived: sum of 3 quarters · filed 2016-02-11 | ||
| 2014-03-31 | $667.00K 10-Q · filed 2014-05-01 | $667.00K derived: sum of 2 quarters · filed 2016-02-11 | |||
| 2013-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-11 | $144.97M 10-K · filed 2016-02-11 | |||
| 2013-09-30 | $144.97M 10-Q · filed 2014-10-30 | ||||
| 2012-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-12 | $39.26M derived: sum of 2 quarters · filed 2015-02-12 | $43.20M 10-K · filed 2015-02-12 | ||
| 2012-09-30 | $39.26M derived: 10-Q 9 month − 10-Q 6 month · filed 2013-10-31 | $43.20M 10-Q · filed 2013-10-31 | |||
| 2012-06-30 | $3.94M 10-Q · filed 2013-08-01 | ||||
| 2011-12-31 | $227.12M 10-K · filed 2014-02-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| INCYTE CORP (INCY) | United States | $24.855B | 13.14 |
| Medpace Holdings, Inc. (MEDP) | United States | $17.316B | 30.09 |
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) | United States | $14.060B | -43.97 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| NRC HEALTH (NRC) | United States | $0.450B | 42.50 |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| bioAffinity Technologies, Inc. (BIAF) | United States | $0.063B | |
| OneMedNet Corp (ONMD) | $0.042B | ||
| iSpecimen Inc. (ISPC) | United States | $0.003B |